155 related articles for article (PubMed ID: 23627984)
1. Patients with prehypertension - do we have enough evidence to treat them?
Marta M; Zanchetti A; Wong ND; Malyszko J; Rysz J; Banach M
Curr Vasc Pharmacol; 2014; 12(4):586-97. PubMed ID: 23627984
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive therapy versus alternative therapeutic options for prehypertension: an evidence-based approach.
Gaddam KK; Ventura H; Lavie CJ
Future Cardiol; 2012 Jan; 8(1):115-22. PubMed ID: 22185450
[TBL] [Abstract][Full Text] [Related]
3. Prehypertension: the rationale for early drug therapy.
Fuchs FD
Cardiovasc Ther; 2010 Dec; 28(6):339-43. PubMed ID: 20553286
[TBL] [Abstract][Full Text] [Related]
4. Prehypertension and the cardiometabolic syndrome: pathological and clinical consequences.
Duprez D; Toleuova A
Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1725-33. PubMed ID: 24215200
[TBL] [Abstract][Full Text] [Related]
5. Effects of prehypertension and hypertension subtype on cardiovascular disease in the Asia-Pacific Region.
Arima H; Murakami Y; Lam TH; Kim HC; Ueshima H; Woo J; Suh I; Fang X; Woodward M;
Hypertension; 2012 Jun; 59(6):1118-23. PubMed ID: 22547441
[TBL] [Abstract][Full Text] [Related]
6. Prehypertension: an opportunity for a new public health paradigm.
Egan BM; Lackland DT; Jones DW
Cardiol Clin; 2010 Nov; 28(4):561-9. PubMed ID: 20937441
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic treatment for prehypertension: to treat or not to treat?
Martin JF; Martin LN; Cipullo JP
Recent Pat Cardiovasc Drug Discov; 2009 Jun; 4(2):133-41. PubMed ID: 19519555
[TBL] [Abstract][Full Text] [Related]
8. Prehypertension - time to act.
Gupta P; Nagaraju SP; Gupta A; Mandya Chikkalingaiah KB
Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):223-33. PubMed ID: 22382212
[TBL] [Abstract][Full Text] [Related]
9. Is it time to target prehypertension.
Whaley-Connell A; Sowers JR
Cardiovasc Ther; 2010 Dec; 28(6):337-8. PubMed ID: 21050419
[No Abstract] [Full Text] [Related]
10. Prehypertension as a risk factor for cardiovascular diseases.
Suri MF; Qureshi AI
J Cardiovasc Nurs; 2006; 21(6):478-82; quiz 483-4. PubMed ID: 17293739
[TBL] [Abstract][Full Text] [Related]
11. Commentary: Using Impedance Cardiography to Detect Asymptomatic Cardiovascular Disease in Prehypertensive Adults with Risk Factors.
DeMarzo AP
High Blood Press Cardiovasc Prev; 2018 Jun; 25(2):219-221. PubMed ID: 29470788
[TBL] [Abstract][Full Text] [Related]
12. Preventing the progression of prehypertension to hypertension: role of antihypertensives.
Fuchs FD; de Mello RB; Fuchs SC
Curr Hypertens Rep; 2015 Jan; 17(1):505. PubMed ID: 25432897
[TBL] [Abstract][Full Text] [Related]
13. Trends in Prehypertension and Hypertension Risk Factors in US Adults: 1999-2012.
Booth JN; Li J; Zhang L; Chen L; Muntner P; Egan B
Hypertension; 2017 Aug; 70(2):275-284. PubMed ID: 28607131
[TBL] [Abstract][Full Text] [Related]
14. [Where is the treatment of hypertension heading?].
Souček M
Vnitr Lek; 2013 Aug; 59(8):720-3. PubMed ID: 24007230
[TBL] [Abstract][Full Text] [Related]
15. Impact of lower range of prehypertension on cardiovascular events in a general population: the Hisayama Study.
Fukuhara M; Arima H; Ninomiya T; Hata J; Yonemoto K; Doi Y; Hirakawa Y; Matsumura K; Kitazono T; Kiyohara Y
J Hypertens; 2012 May; 30(5):893-900. PubMed ID: 22388232
[TBL] [Abstract][Full Text] [Related]
16. Randomised, double-blind, placebo-controlled, assessment of the efficacy and safety of dietary supplements in prehypertension.
Pelliccia F; Pasceri V; Marazzi G; Arrivi A; Cacciotti L; Pannarale G; Speciale G; Greco C; Gaudio C
J Hum Hypertens; 2017 Oct; 31(10):647-653. PubMed ID: 28447625
[TBL] [Abstract][Full Text] [Related]
17. Prehypertension and risk of cardiovascular disease.
Atilla K; Vasan RS
Expert Rev Cardiovasc Ther; 2006 Jan; 4(1):111-7. PubMed ID: 16375633
[TBL] [Abstract][Full Text] [Related]
18. The management of prehypertension in young adults.
Jun M; Xiang Y
Saudi Med J; 2020 Mar; 41(3):223-231. PubMed ID: 32114593
[TBL] [Abstract][Full Text] [Related]
19. Arterial 'prehypertension': a useful concept for drug companies, useless for patients.
Prescrire Int; 2007 Apr; 16(88):73-5. PubMed ID: 17460859
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
